83 related articles for article (PubMed ID: 2778707)
1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
Männistö PT; Hanhijärvi H; Havas A; Vuorela A; Komulainen H; Rauramaa V
J Pharmacol Exp Ther; 1989 Sep; 250(3):1028-33. PubMed ID: 2778707
[TBL] [Abstract][Full Text] [Related]
2. Time course of the antibacterial activity of erythromycin stearate and erythromycin acistrate against two Staphylococcus aureus strains in vitro.
Korkeala H; Männistö PT
J Antimicrob Chemother; 1988 Aug; 22(2):127-33. PubMed ID: 3182415
[TBL] [Abstract][Full Text] [Related]
3. Comparative liver toxicity of various erythromycin derivatives in animals.
Viluksela M; Hanhijärvi H; Husband RF; Kosma VM; Collan Y; Männistö PT
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():9-27. PubMed ID: 3391880
[TBL] [Abstract][Full Text] [Related]
4. Penetration of erythromycin into periapical lesions after repeated doses of erythromycin acistrate and erythromycin stearate: a pilot study.
Tuominen RK; Lehtinen R; Peltola J; Wikberg R; Gordin A; Kokkonen P; Pohto P
Oral Surg Oral Med Oral Pathol; 1991 Jun; 71(6):684-8. PubMed ID: 2062521
[TBL] [Abstract][Full Text] [Related]
5. Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
Fernandes PB; Swanson RN; Hardy DJ; McDonald EJ; Ramer N
Drugs Exp Clin Res; 1988; 14(7):441-4. PubMed ID: 2977115
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis.
Rostila T; Visa K; Gordin A; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():113-9. PubMed ID: 3391873
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema.
Salo OP; Gordin A; Brandt H; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():101-6. PubMed ID: 3391871
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate.
Gordin A; Männistö PT; Antikainen R; Savolainen S; Ylikoski J; Kokkonen P; Rauramaa V
Antimicrob Agents Chemother; 1988 Jul; 32(7):1019-24. PubMed ID: 3190191
[TBL] [Abstract][Full Text] [Related]
9. Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers.
Männistö PT; Taskinen J; Ottoila P; Solkinen A; Vuorela A; Nykänen S
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():33-43. PubMed ID: 3391874
[TBL] [Abstract][Full Text] [Related]
10. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
Wiesner B; Wilen-Rosenqvist G; Lehtonen L
Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
[TBL] [Abstract][Full Text] [Related]
11. Effect of erythromycin on the oro-caecal transit time in man.
Lehtola J; Jauhonen P; Kesäniemi A; Wikberg R; Gordin A
Eur J Clin Pharmacol; 1990; 39(6):555-8. PubMed ID: 2095341
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Erythromycin Stearate (CAS No. 643-22-1) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1988 Dec; 338():1-167. PubMed ID: 12732898
[TBL] [Abstract][Full Text] [Related]
13. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
14. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts.
Gordin A; Salmi HA; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():93-9. PubMed ID: 3391881
[TBL] [Abstract][Full Text] [Related]
16. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
[TBL] [Abstract][Full Text] [Related]
17. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study.
Godin B; Touitou E; Rubinstein E; Athamna A; Athamna M
J Antimicrob Chemother; 2005 Jun; 55(6):989-94. PubMed ID: 15857943
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial efficacy of erythromycin stearate. A report from the general Practitioner Research Group.
Practitioner; 1974 Jan; 212(267):120-2. PubMed ID: 4591200
[No Abstract] [Full Text] [Related]
19. Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine.
De Bernardi M; Feletti F; Gazzani G; Fregnan GB
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):444-7. PubMed ID: 3198299
[TBL] [Abstract][Full Text] [Related]
20. DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.
Bürli RW; Kaizerman JA; Duan JX; Jones P; Johnson KW; Iwamoto M; Truong K; Hu W; Stanton T; Chen A; Touami S; Gross M; Jiang V; Ge Y; Moser HE
Bioorg Med Chem Lett; 2004 May; 14(9):2067-72. PubMed ID: 15080980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
